Hypofractionated radiotherapy for advanced non-small-cell lung cancer: Is the LINAC half full?

被引:5
|
作者
Bogart, JA [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Radiat Oncol, Syracuse, NY USA
关键词
D O I
10.1200/JCO.2004.12.938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:765 / 768
页数:4
相关论文
共 50 条
  • [41] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [42] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
  • [43] Optimal chemotherapy in advanced non-small-cell lung cancer
    Pohl, G
    Malayeri, R
    Doweik, L
    Minar, W
    Pirker, R
    LUNG CANCER: CURRENT TOPICS, 2001, : 125 - 133
  • [44] CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER
    WALLING, J
    RESPIRATORY MEDICINE, 1994, 88 (09) : 649 - 657
  • [45] Targeted therapy in advanced non-small-cell lung cancer
    Gettinger, Scott
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 29 (03) : 291 - 301
  • [46] Maintenance chemotherapy in advanced non-small-cell lung cancer
    Jassem, Jacek
    LANCET ONCOLOGY, 2012, 13 (03): : 217 - 218
  • [47] Immunotherapy in advanced non-small-cell lung cancer withEGFRmutations
    Liu, Fangfang
    Yuan, Xun
    Jiang, Jizong
    Chu, Qian
    IMMUNOTHERAPY, 2020, 12 (16) : 1195 - 1207
  • [48] Axitinib for the treatment of advanced non-small-cell lung cancer
    King, Judy W.
    Lee, Siow-Ming
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (06) : 765 - 773
  • [49] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    LANCET, 2006, 367 (9507): : 299 - 300
  • [50] Afatinib for the treatment of advanced non-small-cell lung cancer
    Genova, Carlo
    Rijavec, Erika
    Barletta, Giulia
    Burrafato, Giovanni
    Biello, Federica
    Dal Bello, Maria Giovanna
    Coco, Simona
    Truini, Anna
    Alama, Angela
    Boccardo, Francesco
    Grossi, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (06) : 889 - 903